Moffitt Opens Outpatient Center at Speros

Moffitt First Connect Office To Open This September in Ocala

New facility will serve as an access point and care coordination office, helping connect patients with oncology specialists and services across Moffitt locations beginning Sept. 14

FDA Approval Marks New Era for Pancreatic Cancer Treatment

First-in-class targeted therapy nearly doubles median overall survival for patients with metastatic pancreatic cancer

Meet Moffitt’s 2026 Midyear DAISY and Sunflower Award Winners

Nurses, medical assistants and oncology technicians recognized for making a difference in the lives of Moffitt patients

5 Gynecologic Cancer Symptoms You Shouldn’t Ignore

Not every gynecologic cancer has an effective screening test, making it especially important to know what changes in your body deserve a conversation with your doctor

FDA Approves Rusfertide, Offering a New Option for Polycythemia Vera

For Danielle Sweet, the weekly injection helped end nearly four years of exhausting phlebotomy

Grief Isn’t Linear: What to Know During the Cancer Journey

Grief can take many forms throughout cancer, and there is no single right way to navigate it

Dolly Parton’s Death Shines Light on the Power of Clinical Trials

Her sister’s tribute revealed Dolly’s wish to help future cancer patients

FDA Approves New Type of Treatment for People With Multiple Myeloma

First-in-class therapy offers a new option for patients whose disease has returned after earlier treatment

Moffitt Launches Radiopharmaceutical Program at Speros

Treatment targets cancer cells more precisely using radioactive isotopes